16:00 - 16:40, Thursday, November 12, 2009 [Main Hall]

Chairpersons:

Tanri Shiozawa (Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Japan)

Yong Li (Cancer Care Centre, St George Hospital University of New South Wales, Australia)

O-9  STUDIES IN THE MULTIMODAL MANAGEMENT OF LOCALLY ADVANCED UTERINE CERVICAL CANCER

Selvaluxmy Ganesarajah, Shanta Viswanathan, Swaminathan R, Rama R

Radiation Oncology, Cancer Instiute (WIA), Chennai, India

O-10  Identification of STIP-1 as a Diagnostic and Therapeutic Biomarker Candidate for Ovarian Cancer by two-dimensional DITA

BoWook Kim, HanByoul Cho, JaeHoon Kim

Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Korea

O-11  ER-60 (PDIA3) protein is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139

Doo Byung Chay, Jae Hoon Kim

Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Korea

 YIA from Korean Cancer Association  O-12  PRECLINICAL STUDIES USING MONOCLONAL ANTI-MUC1 AND DOCETAXEL: A NOVEL STRATEGY FOR TREATING ADVANCED EPITHELIAL OVARIAN CANCER

Li Wang¹, Li Wang¹, Hongmin Chen¹, Fenghua Liu¹, Michele Madigan², Jingli Hao³, Carl Power³, Kate Patterson⁴, Julia Beretov⁵, Mohammad Pourgholami⁶, Philippa O’Brien⁴, Alan Perkins⁷, John Kearsley⁸, Yong Li¹

¹Department of Gynecologic Oncology, Henan Tumor Hospital, China, ²School of Optometry and Vision Science, University of New South Wales, Australia, ³Faculty of Medicine, University of New South Wales, Australia, ⁴Garvan Institute of Medical Research, Darlinghurst, Australia, ⁵Anatomical Pathology, St George Hospital, NSW 2217, Australia, ⁶Department of Surgery, St George Hospital, Australia, ⁷Academic Medical Physics, Medical School, Queen’s Medical Centre, UK, ⁸Cancer Care Centre, St George Hospital, Gray St, Kogarah, Australia

↑ Page Top